Current cancer drug targets
Advances in Immune Checkpoint Inhibitors for the Treatment of Non-Small-Cell Lung Cancer with Central Nervous System Metastases: A Review.
Yuan Meng, Lihan Shang, Jie Yang, Xiaoqun Wang, Yuanyuan Wang, Siyuan Cui, Fanming Kong
Published: 202510.2174/0115680096375189250923070038
Abstract
Central nervous system (CNS) metastasis represents a severe complication in pa-tients with advanced non-small cell lung cancer (NSCLC), significantly impacting both quality of life and prognosis. Immune checkpoint inhibitor (ICI)-based regimens have…
Preview only. Read the full abstract at the source